Literature DB >> 19563754

Structure of N-terminal domain of NPC1 reveals distinct subdomains for binding and transfer of cholesterol.

Hyock Joo Kwon1, Lina Abi-Mosleh, Michael L Wang, Johann Deisenhofer, Joseph L Goldstein, Michael S Brown, Rodney E Infante.   

Abstract

LDL delivers cholesterol to lysosomes by receptor-mediated endocytosis. Exit of cholesterol from lysosomes requires two proteins, membrane-bound Niemann-Pick C1 (NPC1) and soluble NPC2. NPC2 binds cholesterol with its isooctyl side chain buried and its 3beta-hydroxyl exposed. Here, we describe high-resolution structures of the N-terminal domain (NTD) of NPC1 and complexes with cholesterol and 25-hydroxycholesterol. NPC1(NTD) binds cholesterol in an orientation opposite to NPC2: 3beta-hydroxyl buried and isooctyl side chain exposed. Cholesterol transfer from NPC2 to NPC1(NTD) requires reorientation of a helical subdomain in NPC1(NTD), enlarging the opening for cholesterol entry. NPC1 with point mutations in this subdomain (distinct from the binding subdomain) cannot accept cholesterol from NPC2 and cannot restore cholesterol exit from lysosomes in NPC1-deficient cells. We propose a working model wherein after lysosomal hydrolysis of LDL-cholesteryl esters, cholesterol binds NPC2, which transfers it to NPC1(NTD), reversing its orientation and allowing insertion of its isooctyl side chain into the outer lysosomal membranes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19563754      PMCID: PMC2739658          DOI: 10.1016/j.cell.2009.03.049

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  40 in total

1.  Substructure solution with SHELXD.

Authors:  Thomas R Schneider; George M Sheldrick
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2002-09-28

Review 2.  Clathrin-mediated endocytosis before fluorescent proteins.

Authors:  Michael G Roth
Journal:  Nat Rev Mol Cell Biol       Date:  2006-01       Impact factor: 94.444

3.  Purified NPC1 protein. I. Binding of cholesterol and oxysterols to a 1278-amino acid membrane protein.

Authors:  Rodney E Infante; Lina Abi-Mosleh; Arun Radhakrishnan; Jarrod D Dale; Michael S Brown; Joseph L Goldstein
Journal:  J Biol Chem       Date:  2007-11-06       Impact factor: 5.157

4.  The titerless infected-cells preservation and scale-up (TIPS) method for large-scale production of NO-sensitive human soluble guanylate cyclase (sGC) from insect cells infected with recombinant baculovirus.

Authors:  David J Wasilko; S Edward Lee; Kim J Stutzman-Engwall; Beverly A Reitz; Thomas L Emmons; Karl J Mathis; Michael J Bienkowski; Alfredo G Tomasselli; H David Fischer
Journal:  Protein Expr Purif       Date:  2009-01-11       Impact factor: 1.650

Review 5.  Protein sensors for membrane sterols.

Authors:  Joseph L Goldstein; Russell A DeBose-Boyd; Michael S Brown
Journal:  Cell       Date:  2006-01-13       Impact factor: 41.582

Review 6.  A receptor-mediated pathway for cholesterol homeostasis.

Authors:  M S Brown; J L Goldstein
Journal:  Science       Date:  1986-04-04       Impact factor: 47.728

Review 7.  Principles of lysosomal membrane digestion: stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids.

Authors:  Thomas Kolter; Konrad Sandhoff
Journal:  Annu Rev Cell Dev Biol       Date:  2005       Impact factor: 13.827

8.  A coat of glycoconjugates on the inner surface of the lysosomal membrane in the rat kidney.

Authors:  W F Neiss
Journal:  Histochemistry       Date:  1984

9.  Structural basis of sterol binding by NPC2, a lysosomal protein deficient in Niemann-Pick type C2 disease.

Authors:  Sujuan Xu; Brian Benoff; Heng-Ling Liou; Peter Lobel; Ann M Stock
Journal:  J Biol Chem       Date:  2007-06-14       Impact factor: 5.157

10.  Structure of a cholesterol-binding protein deficient in Niemann-Pick type C2 disease.

Authors:  Natalia Friedland; Heng-Ling Liou; Peter Lobel; Ann M Stock
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-18       Impact factor: 11.205

View more
  287 in total

1.  Characterization of the Niemann-Pick C pathway in alveolar type II cells and lamellar bodies of the lung.

Authors:  Blair R Roszell; Jian-Qin Tao; Kevin J Yu; Shaohui Huang; Sandra R Bates
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-02-24       Impact factor: 5.464

2.  STARTing to understand MLN64 function in cholesterol transport.

Authors:  Attilio Rigotti; David E Cohen; Silvana Zanlungo
Journal:  J Lipid Res       Date:  2010-05-28       Impact factor: 5.922

Review 3.  The potential of histone deacetylase inhibitors in Niemann - Pick type C disease.

Authors:  Michael Maceyka; Sheldon Milstien; Sarah Spiegel
Journal:  FEBS J       Date:  2013-09-23       Impact factor: 5.542

4.  δ-Tocopherol reduces lipid accumulation in Niemann-Pick type C1 and Wolman cholesterol storage disorders.

Authors:  Miao Xu; Ke Liu; Manju Swaroop; Forbes D Porter; Rohini Sidhu; Sally Firnkes; Sally Finkes; Daniel S Ory; Juan J Marugan; Jingbo Xiao; Noel Southall; William J Pavan; Cristin Davidson; Steven U Walkley; Alan T Remaley; Ulrich Baxa; Wei Sun; John C McKew; Christopher P Austin; Wei Zheng
Journal:  J Biol Chem       Date:  2012-10-03       Impact factor: 5.157

5.  Quantitative Analysis of the Proteome Response to the Histone Deacetylase Inhibitor (HDACi) Vorinostat in Niemann-Pick Type C1 disease.

Authors:  Kanagaraj Subramanian; Navin Rauniyar; Mathieu Lavalleé-Adam; John R Yates; William E Balch
Journal:  Mol Cell Proteomics       Date:  2017-08-31       Impact factor: 5.911

6.  Sphingolipid signalling mediates mitochondrial dysfunctions and reduced chronological lifespan in the yeast model of Niemann-Pick type C1.

Authors:  Rita Vilaça; Elísio Silva; André Nadais; Vítor Teixeira; Nabil Matmati; Joana Gaifem; Yusuf A Hannun; Maria Clara Sá Miranda; Vítor Costa
Journal:  Mol Microbiol       Date:  2013-12-12       Impact factor: 3.501

7.  2-Hydroxypropyl-β-cyclodextrin is the active component in a triple combination formulation for treatment of Niemann-Pick C1 disease.

Authors:  Jessica Davidson; Elizabeth Molitor; Samantha Moores; Sarah E Gale; Kanagaraj Subramanian; Xuntian Jiang; Rohini Sidhu; Pamela Kell; Jesse Zhang; Hideji Fujiwara; Cristin Davidson; Paul Helquist; Bruce J Melancon; Michael Grigalunas; Gang Liu; Farbod Salahi; Olaf Wiest; Xin Xu; Forbes D Porter; Nina H Pipalia; Dana L Cruz; Edward B Holson; Jean E Schaffer; Steven U Walkley; Frederick R Maxfield; Daniel S Ory
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2019-04-30       Impact factor: 4.698

8.  How well does cholesteryl hemisuccinate mimic cholesterol in saturated phospholipid bilayers?

Authors:  Waldemar Kulig; Joona Tynkkynen; Matti Javanainen; Moutusi Manna; Tomasz Rog; Ilpo Vattulainen; Pavel Jungwirth
Journal:  J Mol Model       Date:  2014-02-14       Impact factor: 1.810

Review 9.  Treatment of Niemann--pick type C disease by histone deacetylase inhibitors.

Authors:  Paul Helquist; Frederick R Maxfield; Norbert L Wiech; Olaf Wiest
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

10.  Conditional Niemann-Pick C mice demonstrate cell autonomous Purkinje cell neurodegeneration.

Authors:  Matthew J Elrick; Chris D Pacheco; Ting Yu; Nahid Dadgar; Vikram G Shakkottai; Christopher Ware; Henry L Paulson; Andrew P Lieberman
Journal:  Hum Mol Genet       Date:  2009-12-10       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.